ZELTIQ Aesthetics, Inc.

( )
ZLTQ After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Medical Specialties
DHRDanaher Corp. 1.10%305.660.7%$613.02m
TMOThermo Fisher Scientific, Inc. 0.28%538.501.0%$611.35m
ABTAbbott Laboratories -0.41%121.620.8%$552.52m
ISRGIntuitive Surgical, Inc. -0.87%990.882.3%$456.67m
MDTMedtronic Plc -2.30%128.440.6%$445.52m
ALGNAlign Technology, Inc. 0.95%708.016.3%$440.86m
DXCMDexCom, Inc. -1.28%514.537.8%$351.17m
SYKStryker Corp. -2.02%262.611.3%$312.50m
BSXBoston Scientific Corp. -2.75%44.291.0%$293.47m
NURONeuroMetrix, Inc. -8.80%13.267.7%$289.19m
AAgilent Technologies, Inc. 0.21%154.181.6%$283.92m
EWEdwards Lifesciences Corp. -0.26%114.400.4%$280.33m
IDXXIDEXX Laboratories, Inc. 0.40%698.483.8%$262.45m
BDXBecton, Dickinson & Co. -0.35%254.881.0%$248.05m
BAXBaxter International, Inc. -1.48%75.151.8%$220.57m

Company Profile

Zeltiq (pronounced Zel ′teek) Aesthetics, founded in 2005, is a science-based medical device company dedicated to the development of non-invasive procedures for the reduction of unwanted fat tissue. The Zeltiq approach utilizes a patented method called Cryolipolysis™ (the use of precisely controlled cooling to remove fat) that is designed to target only fat cells and not harm the skin or other tissue. The Zeltiq device is cleared by the FDA in the Unites States for various applications related to skin cooling during dermatologic treatments.